{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:29:44Z","timestamp":1722889784316},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s10689-011-9435-0","type":"journal-article","created":{"date-parts":[[2011,3,21]],"date-time":"2011-03-21T05:37:16Z","timestamp":1300685836000},"page":"505-514","source":"Crossref","is-referenced-by-count":6,"title":["Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer"],"prefix":"10.1007","volume":"10","author":[{"name":"kConFab Investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. E.","family":"Kiely","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. L.","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. L.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Stanhope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Weideman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"McLachlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,22]]},"reference":[{"issue":"5","key":"9435_CR1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130 [erratum appears in Am J Hum Genet. 2003 Sep;73(3):709]","journal-title":"Am J Hum Genet"},{"issue":"3","key":"9435_CR2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676\u2013689","journal-title":"Am J Hum Genet"},{"issue":"5645","key":"9435_CR3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643\u2013646","journal-title":"Science"},{"issue":"20","key":"9435_CR4","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","volume":"336","author":"JP Struewing","year":"1997","unstructured":"Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336(20):1401\u20131408","journal-title":"N Engl J Med"},{"issue":"5","key":"9435_CR5","first-page":"467","volume":"10","author":"JM Satagopan","year":"2001","unstructured":"Satagopan JM, Offit K, Foulkes W et al (2001) The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 10(5):467\u2013473","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"32","key":"9435_CR6","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","volume":"26","author":"K Levanon","year":"2008","unstructured":"Levanon K, Crum C, Drapkin R (2008) New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol 26(32):5284\u20135293","journal-title":"J Clin Oncol"},{"key":"9435_CR7","unstructured":"National Breast and Ovarian Cancer Centre (NBOCC) (2011) Familial Risk Assessment - Breast and Ovarian Cancer (FRA-BOC). http:\/\/www.nbocc.org.au\/fraboc\/"},{"issue":"9","key":"9435_CR8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archinte.155.9.905","volume":"155","author":"RA Kerber","year":"1995","unstructured":"Kerber RA, Slattery ML (1995) The impact of family history on ovarian cancer risk. The Utah Population Database. Arch Intern Med 155(9):905\u2013912","journal-title":"Arch Intern Med"},{"issue":"5","key":"9435_CR9","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.20.5.1260","volume":"20","author":"L Scheuer","year":"2002","unstructured":"Scheuer L, Kauff N, Robson M et al (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. [see comment]. J Clin Oncol 20(5):1260\u20131268","journal-title":"J Clin Oncol"},{"issue":"21","key":"9435_CR10","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"TR Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346(21):1616\u20131622","journal-title":"N Engl J Med"},{"issue":"14","key":"9435_CR11","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/95.14.1072","volume":"95","author":"JL Rutter","year":"2003","unstructured":"Rutter JL, Wacholder S, Chetrit A et al (2003) Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study. J Natl Cancer Inst 95(14):1072\u20131078","journal-title":"J Natl Cancer Inst"},{"issue":"28","key":"9435_CR12","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2005.04.5260","volume":"24","author":"JG Guillem","year":"2006","unstructured":"Guillem JG, Wood WC, Moley JF et al (2006) ASCO\/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol 24(28):4642\u20134660","journal-title":"J Clin Oncol"},{"issue":"3","key":"9435_CR13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","volume":"7","author":"SM Domchek","year":"2006","unstructured":"Domchek SM, Friebel TM, Neuhausen SL et al (2006) Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol 7(3):223\u2013229","journal-title":"Lancet Oncol"},{"issue":"2","key":"9435_CR14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80\u201387","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"9435_CR15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ygyno.2004.02.013","volume":"93","author":"B Rosen","year":"2004","unstructured":"Rosen B, Kwon J, Fung Kee Fung M, Gagliardi A, Chambers A (2004) Systematic review of management options for women with a hereditary predisposition to ovarian cancer. Gynecol Oncol 93(2):280\u2013286","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9435_CR16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","volume":"23","author":"CB Powell","year":"2005","unstructured":"Powell CB, Kenley E, Chen LM et al (2005) Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. J Clin Oncol 23(1):127\u2013132","journal-title":"J Clin Oncol"},{"issue":"2","key":"9435_CR17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ygyno.2005.05.002","volume":"98","author":"Society of Gynecologic Oncologists","year":"2005","unstructured":"Society of Gynecologic Oncologists (2005) Clinical practice committee statement on prophylactic salpingo-oophorectomy. Gynecol Oncol 98(2):179\u2013181","journal-title":"Gynecol Oncol"},{"issue":"10","key":"9435_CR18","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","volume":"25","author":"TJ Colgan","year":"2001","unstructured":"Colgan TJ, Murphy J, Cole DE, Narod S, Rosen B (2001) Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status. Am J Surg Pathol 25(10):1283\u20131289","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"9435_CR19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","volume":"80","author":"PJ Paley","year":"2001","unstructured":"Paley PJ, Swisher EM, Garcia RL et al (2001) Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. Gynecol Oncol 80(2):176\u2013180","journal-title":"Gynecol Oncol"},{"issue":"2","key":"9435_CR20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ygyno.2003.12.009","volume":"92","author":"BY Karlan","year":"2004","unstructured":"Karlan BY (2004) Defining cancer risks for BRCA germline mutation carriers: implications for surgical prophylaxis. Gynecol Oncol 92(2):519\u2013520","journal-title":"Gynecol Oncol"},{"issue":"2","key":"9435_CR21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2004.03.016","volume":"93","author":"ND Kauff","year":"2004","unstructured":"Kauff ND, Barakat RR (2004) Surgical risk-reduction in carriers of BRCA mutations: where do we go from here? Gynecol Oncol 93(2):277\u2013279","journal-title":"Gynecol Oncol"},{"issue":"3","key":"9435_CR22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ygyno.2006.01.006","volume":"102","author":"JA Villella","year":"2006","unstructured":"Villella JA, Parmar M, Donohue K, Fahey C, Piver MS, Rodabaugh K (2006) Role of prophylactic hysterectomy in patients at high risk for hereditary cancers. Gynecol Oncol 102(3):475\u2013479","journal-title":"Gynecol Oncol"},{"issue":"3","key":"9435_CR23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/gyno.2002.6638","volume":"85","author":"TJ Colgan","year":"2002","unstructured":"Colgan TJ, Boerner SL, Murphy J, Cole DE, Narod S, Rosen B (2002) Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy. Gynecol Oncol 85(3):397\u2013403","journal-title":"Gynecol Oncol"},{"issue":"14","key":"9435_CR24","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1200\/JCO.2000.18.14.2728","volume":"18","author":"KH Lu","year":"2000","unstructured":"Lu KH, Garber JE, Cramer DW et al (2000) Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy. J Clin Oncol 18(14):2728\u20132732","journal-title":"J Clin Oncol"},{"issue":"25","key":"9435_CR25","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","volume":"25","author":"MJ Callahan","year":"2007","unstructured":"Callahan MJ, Crum CP, Medeiros F et al (2007) Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 25(25):3985\u20133990","journal-title":"J Clin Oncol"},{"issue":"8","key":"9435_CR26","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.bjc.6601692","volume":"90","author":"RI Olivier","year":"2004","unstructured":"Olivier RI, van Beurden M, Lubsen MA et al (2004) Clinical outcome of prophylactic oophorectomy in BRCA1\/BRCA2 mutation carriers and events during follow-up. Br J Cancer 90(8):1492\u20131497","journal-title":"Br J Cancer"},{"issue":"1","key":"9435_CR27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","volume":"87","author":"K Leeper","year":"2002","unstructured":"Leeper K, Garcia R, Swisher E, Goff B, Greer B, Paley P (2002) Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol 87(1):52\u201356","journal-title":"Gynecol Oncol"},{"issue":"9","key":"9435_CR28","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1200\/JCO.2000.18.9.1980","volume":"18","author":"A Eisen","year":"2000","unstructured":"Eisen A, Rebbeck TR, Wood WC, Weber BL (2000) Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol 18(9):1980\u20131995","journal-title":"J Clin Oncol"},{"issue":"1","key":"9435_CR29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","volume":"100","author":"A Finch","year":"2006","unstructured":"Finch A, Shaw P, Rosen B, Murphy J, Narod SA, Colgan TJ (2006) Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol 100(1):58\u201364","journal-title":"Gynecol Oncol"},{"issue":"10","key":"9435_CR30","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/01.pas.0000202161.80739.ac","volume":"30","author":"ML Carcangiu","year":"2006","unstructured":"Carcangiu ML, Peissel B, Pasini B, Spatti G, Radice P, Manoukian S (2006) Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature. Am J Surg Pathol 30(10):1222\u20131230","journal-title":"Am J Surg Pathol"},{"key":"9435_CR31","unstructured":"Rhiem K, Foth D, Wappenschmidt B et al (2010) Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers. Arch Gynecol Obstet. 2010\/04\/30"},{"key":"9435_CR32","unstructured":"Kathleen Cunningham Consortium for Research into Familial Breast Cancer: kConFab. http:\/\/www.kconfab.org"},{"issue":"1","key":"9435_CR33","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/bcr1377","volume":"8","author":"GJ Mann","year":"2006","unstructured":"Mann GJ, Thorne H, Balleine RL et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8(1):R12","journal-title":"Breast Cancer Res"},{"issue":"2","key":"9435_CR34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10689-004-6129-x","volume":"4","author":"KA Phillips","year":"2005","unstructured":"Phillips KA, Butow PN, Stewart AE et al (2005) Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. Fam Cancer 4(2):105\u2013113","journal-title":"Fam Cancer"},{"key":"9435_CR35","unstructured":"Australian Society of Gynaecologic Oncologists. http:\/\/www.asgo.net.au"},{"key":"9435_CR36","unstructured":"StataCorp (2007) Stata statistical software. College Station, Texas, USA"},{"key":"9435_CR37","doi-asserted-by":"crossref","unstructured":"Domchek SM, Friebel TM, Garber JE et al (2010) Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1\/2 mutation carriers. Breast Cancer Res Treat","DOI":"10.1007\/s10549-010-0799-x"},{"issue":"6","key":"9435_CR38","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ajog.2006.03.006","volume":"194","author":"JD Lamb","year":"2006","unstructured":"Lamb JD, Garcia RL, Goff BA, Paley PJ, Swisher EM (2006) Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy. Am J Obstet Gynecol 194(6):1702\u20131709","journal-title":"Am J Obstet Gynecol"},{"issue":"21","key":"9435_CR39","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME et al (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346(21):1609\u20131615","journal-title":"N Engl J Med"},{"issue":"5","key":"9435_CR40","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/IGC.0b013e3181a1b5dc","volume":"19","author":"JE Hirst","year":"2009","unstructured":"Hirst JE, Gard GB, McIllroy K, Nevell D, Field M (2009) High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy. Int J Gynecol Cancer 19(5):826\u2013829","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"9435_CR41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","volume":"5","author":"CP Crum","year":"2007","unstructured":"Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y (2007) Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res 5(1):35\u201344","journal-title":"Clin Med Res"},{"issue":"3","key":"9435_CR42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2009.01.013","volume":"113","author":"AK Folkins","year":"2009","unstructured":"Folkins AK, Jarboe EA, Roh MH, Crum CP (2009) Precursors to pelvic serous carcinoma and their clinical implications. Gynecol Oncol 113(3):391\u2013396","journal-title":"Gynecol Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10689-011-9435-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T06:28:05Z","timestamp":1560061685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-011-9435-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,22]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["9435"],"URL":"https:\/\/doi.org\/10.1007\/s10689-011-9435-0","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2011,3,22]]}}}